BioLineRX Ltd (BLRX) is a publicly traded Healthcare sector company. As of September 16, 2026, BLRX trades at $2.53 with a market cap of $11.78M and a P/E ratio of 0.00. BLRX moved +0.00% today. Year to date, BLRX is -9.03%; over the trailing twelve months it is -32.80%. Its 52-week range spans $2.15 to $7.77. Analyst consensus is buy with an average price target of $26.00. Rallies surfaces BLRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for BLRX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $2.53 |
| Market Cap | $11.78M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.77 |
| 52-Week Low | $2.15 |
| Volume | 1.25K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
1 analysts cover BLRX: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $26.00.